BACKGROUND: Increasing rates of methicillin-resistant Staphylococcus aureus (MRSA) infections on a global scale is a major health concern. In Canada, there are 10 known epidemic types of MRSA as determined by pulsed-field gel electrophoresis (PFGE). Despite the excellent discriminatory power of PFGE, there are several disadvantages of using this technique, such as high degree of labour intensity and the inability to easily develop an MRSA typing database due to the subjective interpretation of results. OBJECTIVES: The purpose of the present study was to determine whether spa typing, an established DNA sequence-based typing method, could be used as an alternative to PFGE for the typing of Canadian MRSA (CMRSA) epidemic isolates. RESULTS: spa types were determined for 1488 CMRSA isolates, and the method was analyzed for its ability to identify and cluster CMRSA1-10 strains. Minimal spanning tree analysis of 1452 spa types revealed individual clonal clusters for PFGE epidemic types CMRSA1, 2, 7 and 8, but spa typing could not distinguish CMRSA5 from CMRSA9 and CMRSA10, and CMRSA3 from CMRSA4 and CMRSA6. However, specific spa types were generally associated with only one PFGE epidemic type. Based on these results, a spa typing guideline for CMRSA isolates was developed and tested using the first 300 MRSA isolates received in 2007 through the Canadian Nosocomial Infection Surveillance Program. CONCLUSIONS: The high concordance of spa types with PFGE epidemic types using this guideline demonstrated the feasibility of spa typing as a more rapid and less technically demanding alternative typing method for MRSA in Canada.
BACKGROUND: Increasing rates of methicillin-resistant Staphylococcus aureus (MRSA) infections on a global scale is a major health concern. In Canada, there are 10 known epidemic types of MRSA as determined by pulsed-field gel electrophoresis (PFGE). Despite the excellent discriminatory power of PFGE, there are several disadvantages of using this technique, such as high degree of labour intensity and the inability to easily develop an MRSA typing database due to the subjective interpretation of results. OBJECTIVES: The purpose of the present study was to determine whether spa typing, an established DNA sequence-based typing method, could be used as an alternative to PFGE for the typing of Canadian MRSA (CMRSA) epidemic isolates. RESULTS: spa types were determined for 1488 CMRSA isolates, and the method was analyzed for its ability to identify and cluster CMRSA1-10 strains. Minimal spanning tree analysis of 1452 spa types revealed individual clonal clusters for PFGE epidemic types CMRSA1, 2, 7 and 8, but spa typing could not distinguish CMRSA5 from CMRSA9 and CMRSA10, and CMRSA3 from CMRSA4 and CMRSA6. However, specific spa types were generally associated with only one PFGE epidemic type. Based on these results, a spa typing guideline for CMRSA isolates was developed and tested using the first 300 MRSA isolates received in 2007 through the Canadian Nosocomial Infection Surveillance Program. CONCLUSIONS: The high concordance of spa types with PFGE epidemic types using this guideline demonstrated the feasibility of spa typing as a more rapid and less technically demanding alternative typing method for MRSA in Canada.
Authors: Fred C Tenover; Linda K McDougal; Richard V Goering; George Killgore; Steven J Projan; Jean B Patel; Paul M Dunman Journal: J Clin Microbiol Date: 2006-01 Impact factor: 5.948
Authors: Richard V Goering; Linda K McDougal; Greg E Fosheim; Kristin K Bonnstetter; Daniel J Wolter; Fred C Tenover Journal: J Clin Microbiol Date: 2007-04-04 Impact factor: 5.948
Authors: B Shopsin; M Gomez; S O Montgomery; D H Smith; M Waddington; D E Dodge; D A Bost; M Riehman; S Naidich; B N Kreiswirth Journal: J Clin Microbiol Date: 1999-11 Impact factor: 5.948
Authors: Ulrich Seybold; Ekaterina V Kourbatova; James G Johnson; Sue J Halvosa; Yun F Wang; Mark D King; Susan M Ray; Henry M Blumberg Journal: Clin Infect Dis Date: 2006-01-25 Impact factor: 9.079
Authors: Alexander Mellmann; Alexander W Friedrich; Nicole Rosenkötter; Jörg Rothgänger; Helge Karch; Ralf Reintjes; Dag Harmsen Journal: PLoS Med Date: 2006-03 Impact factor: 11.069
Authors: Alexander Mellmann; Thomas Weniger; Christoph Berssenbrügge; Jörg Rothgänger; Michael Sammeth; Jens Stoye; Dag Harmsen Journal: BMC Microbiol Date: 2007-10-29 Impact factor: 3.605
Authors: Heather J Adam; Nancy M Laing; C Richard King; Ben Lulashnyk; Daryl J Hoban; George G Zhanel Journal: Antimicrob Agents Chemother Date: 2009-09-08 Impact factor: 5.191
Authors: Maria Pardos de la Gandara; Juan Antonio Raygoza Garay; Michael Mwangi; Jonathan N Tobin; Amanda Tsang; Chamanara Khalida; Brianna D'Orazio; Rhonda G Kost; Andrea Leinberger-Jabari; Cameron Coffran; Teresa H Evering; Barry S Coller; Shirish Balachandra; Tracie Urban; Claude Parola; Scott Salvato; Nancy Jenks; Daren Wu; Rhonda Burgess; Marilyn Chung; Herminia de Lencastre; Alexander Tomasz Journal: J Clin Microbiol Date: 2015-06-10 Impact factor: 5.948
Authors: Vincent Li; Linda Chui; Kimberley Simmonds; Thuha Nguyen; George R Golding; Wadieh Yacoub; Christina Ferrato; Marie Louie Journal: J Clin Microbiol Date: 2014-04-30 Impact factor: 5.948
Authors: Fred C Tenover; Isabella A Tickler; Richard V Goering; Barry N Kreiswirth; José R Mediavilla; David H Persing Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: James A Karlowsky; Philippe R S Lagacé-Wiens; Patricia J Simner; Melanie R DeCorby; Heather J Adam; Andrew Walkty; Daryl J Hoban; George G Zhanel Journal: Antimicrob Agents Chemother Date: 2011-05-02 Impact factor: 5.191
Authors: James A Karlowsky; Heather J Adam; Melanie R Decorby; Philippe R S Lagacé-Wiens; Daryl J Hoban; George G Zhanel Journal: Antimicrob Agents Chemother Date: 2011-03-14 Impact factor: 5.191
Authors: Ryan Yu; Suzanne E Dale; Deborah Yamamura; Vida Stankus; Christine Lee Journal: Can J Infect Dis Med Microbiol Date: 2012 Impact factor: 2.471